Reneo Pharmaceuticals, Inc. - Class A Common Stock (NQ:RPHM)
Price and Volume
Detailed Quote| Volume | 0 |
| Open | 1.820 |
| Bid (Size) | 1.820 (1) |
| Ask (Size) | 1.870 (91) |
| Prev. Close | 1.820 |
| Today's Range | 1.820 - 1.820 |
| 52wk Range | N/A - N/A |
| Shares Outstanding | 33,655,123 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Reneo Pharmaceuticals And 2 Other Stocks Under $5 Executives Are Buying
September 17, 2024
Citizens And 2 Other Penny Stocks Insiders Are Buying
August 15, 2024
Frequently Asked Questions
Is Reneo Pharmaceuticals, Inc. - Class A Common Stock publicly traded?
Yes, Reneo Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.
What exchange does Reneo Pharmaceuticals, Inc. - Class A Common Stock trade on?
Reneo Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Reneo Pharmaceuticals, Inc. - Class A Common Stock?
The ticker symbol for Reneo Pharmaceuticals, Inc. - Class A Common Stock is RPHM on the Nasdaq Stock Market
What is the current price of Reneo Pharmaceuticals, Inc. - Class A Common Stock?
The current price of Reneo Pharmaceuticals, Inc. - Class A Common Stock is 1.820
When was Reneo Pharmaceuticals, Inc. - Class A Common Stock last traded?
The last trade of Reneo Pharmaceuticals, Inc. - Class A Common Stock was at 10/04/24 04:00 PM ET
What is the market capitalization of Reneo Pharmaceuticals, Inc. - Class A Common Stock?
The market capitalization of Reneo Pharmaceuticals, Inc. - Class A Common Stock is 61.25M
How many shares of Reneo Pharmaceuticals, Inc. - Class A Common Stock are outstanding?
Reneo Pharmaceuticals, Inc. - Class A Common Stock has 61M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Facebook
Twitter
YouTube